HER2, an epidermal growth factor receptor protein encoded by the ERBB2 gene, has been found to be over-expressed as a tumour-associated antigen in 80% of GBM cells, signaling a poor prognosis, but not in normal neurons or glial cells (42). Here, ERBB2 is linked to neoplasm.